TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 127 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,534,051 | +13.6% | 371,892 | +9.4% | 0.00% | 0.0% |
| Q1 2024 | $2,230,512 | +341.1% | 340,017 | +336.9% | 0.00% | – |
| Q4 2023 | $505,705 | +13.5% | 77,825 | -12.3% | 0.00% | – |
| Q3 2023 | $445,668 | -78.6% | 88,712 | -62.8% | 0.00% | -100.0% |
| Q2 2023 | $2,085,215 | -25.7% | 238,364 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $2,807,243 | +278950.0% | 237,111 | +139.7% | 0.00% | – |
| Q4 2022 | $1,006 | -99.5% | 98,940 | +197.0% | 0.00% | – |
| Q3 2022 | $196,000 | – | 33,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 714,285 | $2,121,000 | 0.65% |
| Vivo Capital, LLC | 2,675,133 | $7,945,000 | 0.55% |
| Samsara BioCapital, LLC | 289,068 | $859,000 | 0.22% |
| Orbimed Advisors | 3,791,204 | $11,260,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,345,959 | $6,967,000 | 0.16% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,238,800 | $3,679,000 | 0.11% |
| Antara Capital LP | 1,074,834 | $3,192,000 | 0.10% |
| COWEN AND COMPANY, LLC | 85,000 | $252,000 | 0.02% |
| Marquette Asset Management, LLC | 21,802 | $65,000 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 85,851 | $255,000 | 0.01% |